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Abstract
Translocation of the Helicobacter pylori (Hp) cytotoxin-associated gene A (CagA) effector protein via the cag-Type IV
Secretion System (T4SS) into host cells is a major risk factor for severe gastric diseases, including gastric cancer. However,
the mechanism of translocation and the requirements from the host cell for that event are not well understood. The T4SS
consists of inner- and outer membrane-spanning Cag protein complexes and a surface-located pilus. Previously an arginine-
glycine-aspartate (RGD)-dependent typical integrin/ligand type interaction of CagL with a5b1 integrin was reported to be
essential for CagA translocation. Here we report a specific binding of the T4SS-pilus-associated components CagY and the
effector protein CagA to the host cell b1 Integrin receptor. Surface plasmon resonance measurements revealed that CagA
binding to a5b1 integrin is rather strong (dissociation constant, KD of 0.15 nM), in comparison to the reported RGD-
dependent integrin/fibronectin interaction (KD of 15 nM). For CagA translocation the extracellular part of the b1 integrin
subunit is necessary, but not its cytoplasmic domain, nor downstream signalling via integrin-linked kinase. A set of b1
integrin-specific monoclonal antibodies directed against various defined b1 integrin epitopes, such as the PSI, the I-like, the
EGF or the b-tail domain, were unable to interfere with CagA translocation. However, a specific antibody (9EG7), which
stabilises the open active conformation of b1 integrin heterodimers, efficiently blocked CagA translocation. Our data
support a novel model in which the cag-T4SS exploits the b1 integrin receptor by an RGD-independent interaction that
involves a conformational switch from the open (extended) to the closed (bent) conformation, to initiate effector protein
translocation.
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Introduction
Infection with the gastric pathogen Helicobacter pylori (Hp) is
associated with a spectrum of pathologies, ranging from mild
gastritis to peptic ulcers and gastric cancer [1]. However, the
molecular mechanisms underlying the development of Hp-associ-
ated gastroduodenal diseases are still poorly defined. Two major
virulence factors of Hp that have been associated with disease
induction are the vacuolating cytotoxin (VacA) and the cytotoxin-
associated antigen A (CagA), both of which are delivered into
eukaryotic target cells. VacA, a secreted multifunctional protein
toxin, induces intracellular vacuoles in epithelial cells, inhibits T
lymphocyte proliferation and modulates T cell function [reviewed
in 2]. Using the b2 integrin subunit CD18 as a cellular receptor for
uptake [3], VacA efficiently down-regulates transcription of several
cytokines or chemokines in T cells [4]. CagA, an immunodominant
protein of 120–170 kDa, is encoded on the cag pathogenicity island
(cag-PAI). The cag-PAI comprises a total of 27 genes, encoding the
cag-Type IV Secretion System (T4SS) in Hp [5].
Upon direct contact with gastric epithelial cells, CagA is
translocated into host cells via the cag-T4SS [6] and immediately
tyrosine-phosphorylated at a variable number of so-called EPIYA
motifs by kinases of the Src and c-Abl family [7,8]. CagA interacts
with a large set of host proteins in phosphorylation-dependent and
-independent ways and is considered as a bacterial oncoprotein
that exerts multiple effects on host signal transduction pathways,
the cytoskeleton and cellular junctions [reviewed in 9]. A further
hallmark of cag-PAI positive Hp strains is their ability to induce the
secretion of chemokines upon contact with epithelial cells, such as
interleukin-8 (IL-8) [10]. The function of each cag-PAI-encoded
component for CagA delivery and IL-8 secretion has been studied
by a systematic mutagenesis approach [11]. Translocation-
competent Hp strains harbour membrane protrusions consisting
of a central filament, carrying on its surface the cag-PAI encoded
proteins CagY (HP0527), a VirB10 homologous protein [12],
CagX (HP0528, VirB9-homologue) and CagT (HP0532, VirB7-
homologue) [13]. Although the ultrastructure and the biochemical
composition of these protrusions has not been clarified yet, we
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would refer to these structures as type IV secretion system pili.
Furthermore, the a5b1 integrin heterodimer has recently been
identified as a receptor for the Hp pilus-associated adhesin CagL
[14].
Integrins represent a family of about 24 different ab
heterodimeric receptors that mediate cell-cell, cell-extracellular
matrix and cell-pathogen interactions and govern migration and
anchorage of almost all kinds of cells. Each of the non-covalently
associated subunits contains a large N-terminal extracellular
domain, a transmembrane segment and a short C-terminal
cytoplasmic tail. Affinity for biological ligands is regulated by
inside-out and outside-in signalling. The bent conformation of the
integrin heterodimer represents the physiological low-affinity state,
whereas inside–out signalling and ligand binding induces a large-
scale conformational rearrangement, in which the integrin extends
from the bent into an extended, open conformation [15]. Hp
T4SS-pilus-associated CagL was suggested to bind via its arginine-
glycine-aspartate (RGD) motif to a5b1 integrin, a process
described as essential for CagA translocation and activation of
focal adhesion kinase (FAK) and Src kinase [14]. In the present
study we show that further components of the cag-T4SS, such as
CagY (HP0527) and the effector protein CagA interact with
distinct extracellular domains of b1 integrin. These components
are located along or at the tip of the T4SS-pilus. We propose a
model that suggests conformational changes of the integrin
heterodimer as a basis for CagA translocation.
Results
CagA Translocation into Epithelial Cells is Dependent on
b1 Integrin Heterodimers
Hp translocates its effector protein CagA via the cag-T4SS into a
number of different cell types in vitro [16]. Recently it was shown
that CagA translocation is dependent on the interaction of the Hp
T4SS-pilus-associated protein CagL, binding in an RGD-depen-
dent way to a5b1 integrin on the host cell [14]. However, nothing
is known about the mechanism of CagA translocation and the
involvement of other T4SS components in this process. Using a
different approach, we also identified b1 integrin as a cellular
receptor for the cag-T4SS. Three independent Hp strains (P12,
P145, P217) were applied to study host cell requirements for CagA
translocation using several human and animal cell lines (data not
shown). Of special interest were human promyelocytic leukaemia
(HL60) cells, which were fully competent for CagA translocation
(Figure 1A, lanes 1–3 and 7), whereas, HL60 cells differentiated to
a granulocyte-like phenotype (dHL60 cells) revealed only a very
weak CagA-P signal (Figure 1A, lanes 4–6 and 8). Thus, the
capacity of Hp to translocate CagA varies considerably, even for
the same type of cell, dependent on its cellular differentiation
stage. Flow cytometry revealed elevated b2, but significantly
reduced b1 integrin levels on the surface of dHL60, as compared
to HL60 cells (Figure 1C). We therefore concentrated on b1
integrin as a potential receptor for the T4SS. CagA translocation
was completely absent for epithelial (GE11) or fibroblast-like
(GD25) b1 integrin knockout cells, but was functional in
genetically complemented GE11b or GD25b cells (Figure 1B)
[17]. In agreement with Kwok et al. [14], these data indepen-
dently confirmed the important finding that b1 integrin is essential
for CagA translocation.
CagA, CagY and CagI are b1 Integrin Interaction Partners
CagL is the only protein encoded on the cag-PAI which carries
an RGD motif and therefore might be recognized by the a5b1
integrin receptor in a typical integrin/ligand–like fashion.
Whereas Kwok et al. [14] specifically concentrated on the
CagL/a5b1 integrin interaction, we chose a systematic approach
to identify possible T4SS-integrin interactions and applied a yeast
two-hybrid (YTH) screen using the GAL4 Matchmaker system
(Clontech) (Figure 2A). Since various cell lines expressing different
a/b1 integrin combinations proved successful for CagA translo-
cation (data not shown), the b1 subunit was considered as
important and the extracellular portion of the human b1 integrin
gene was used as bait. As prey for the YTH screen each of the 27
cag-PAI-encoded proteins were assayed [18]. Positive interactions
were obtained for the extracellular part of b1 integrin with the N-
terminal region of CagA (HP0547a), the C-terminal (VirB10-
homologous) portion of CagY (HP0527c) and with CagI (HP0540)
(Figure 2A, Figure S1). Similar results were obtained when bait
and prey were exchanged (data not shown).
To confirm the YTH data, pulldown experiments using Hp
T4SS-associated proteins were performed (see Figure S2A for
preparation of extracts) using functional a1b1 and a5b1 integrin
heterodimers (Chemicon) coupled to magnetic beads. CagA was
specifically pulled down from wt cell lysates by a1b1 or a5b1
integrin beads, but not by controls (Tris-blocked beads) (Figure 2B).
The ectopic expression of cagA from the shuttle plasmid pJP66
[19] in a P12DPAI strain demonstrated that CagA alone is able to
interact with b1 integrin without any other component of the cag-
PAI. Preferentially the upper band of CagY and only small
amount of the lower band of CagY was pulled down by the same
procedure (Figure 2B, lower panel). Again, precipitation of CagY
from a cagA-negative Hp background confirmed an interaction of
CagY with integrin, independent of CagA.
The putative interaction of b1 integrin with CagI could not yet
be verified by pulldown assays, due to the lack of a specific
functional antibody against CagI. We therefore used as a further
method a cell-based assay to determine binding of the corre-
sponding GST-Cag fusion proteins to b1 integrin-proficient
(GE11b), versus b1 integrin-deficient cells (GE11) by flow
cytometry (Figure 2C and Figure S2B,C). GST did not bind b1–
integrin-dependent, but purified GST-CagA, GST-CagI and
GST-CagYc bound significantly more efficiently to GE11b as
Author Summary
Integrins are single transmembrane proteins present on
almost all types of cells. They are composed of an a and a
b subunit, which together form the ligand binding pocket,
able to interact with extracellular matrix proteins. The best
known binding domain on integrin ligands is the RGD
domain. Many bacterial, but also viral pathogens exploit
this ligand-binding domain to interact with integrins on
the host cell. Helicobacter pylori, a common bacterial
pathogen associated with gastric diseases, was recently
added to this list. One of H. pylori’s most important factors
associated with gastric pathologies is the CagA protein.
This protein is directly injected into host cells through the
Cag Type IV Secretion System (cag-T4SS). Previous studies
demonstrated that the cag-T4SS requires integrins for the
injection (translocation) of CagA into cells. We provide
evidence that three proteins, CagA, CagI and CagY,
interact with integrins in an RGD-independent way.
Additionally, our data point out that the Cag apparatus
needs the physical capacity of a b1 integrin heterodimer to
change from an active/extended conformation to a closed/
bent conformation. This novel kind of integrin interaction
opens a new way in which pathogens can use receptors on
cells.
b1 Integrin Engagement for CagA Translocation
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Figure 1. Host cell b1 integrin is essential for Hp to translocate and tyrosine-phosphorylate CagA in different cell lines. (A)
Immunoblots to determine translocation of CagA in HL60 versus dHL60 cells. (B) Immunoblots of b1 integrin knockout fibroblasts (GD25), epithelial
cells (GE11) or b1 gene-complemented cells (GD25b, GE11b) infected with Hp strains or media (control). The upper panel shows CagA translocation
using a phosphotyrosine-specific antibody (mAb PY99), the lower panel shows CagA production by Hp. Bands corresponding to Phospho-CagA
(CagA-P) or CagA are indicated by arrows or open arrowheads, respectively. (C) FACS analysis quantifying b1 and b2 integrin surface localization on
HL60 and dHL60 cells using antibody CD29 FITC (b1 integrin) or CD18 PE (b2 integrin). (D) Quantification of co-localization events of Hp wt, DcagA or
DPAI bacteria and b1-integrin by laser scanning confocal microscopy. (E) Confocal micrographs, showing binding of Hp P12-gfp wt (upper panel) or
P12DPAI (lower panel) and b1-integrin-labelled AGS cells (4B7-AlexaFluor568) and areas of co-localization of Hp and b1 integrin (arrows).
doi:10.1371/journal.ppat.1000684.g001
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Figure 2. Identification and verification of Hp T4SS proteins interacting with human b1 integrin. (A) Domain organization of the b1
integrin clone used as bait in a YTH screen and identification of interacting proteins encoded by the cag-PAI used as preys. (+, interaction; 2, no
interaction), tenfold dilution steps still allowing growth of yeast on selective media are indicated by number of ‘‘+’’ signs (see Figure S1). (B) For
pulldown assays, magnetic beads (SiMAG) were loaded with purified functional a1b1 or a5b1 integrin or Tris buffer (control) and incubated with
processed Hp P12 wt or defined mutant strains, as indicated (fraction Soluble II, Figure S2A). Beads were recovered by magnetic forces, washed,
boiled and run for SDS-PAGE. Immunoblotting with a-CagA or a-CagY antibody detects precipitated proteins (arrowheads). (C) Quantification of
binding of purified GST-CagA, GST-CagYc, GST-CagI or GST-Inv397 (30mg/16106 cells) to integrin-deficient GE11 versus integrin-proficient GE11b cells
by flow cytometry. Binding is analysed by a-GST antibody (fold increase in binding versus GST, the values for binding of GST alone has been set to 1).
RPI, repeat region I, RPII, repeat region II, (*, p,0.05; **, p,0.01; ***, p,0.001; students T-test). MF, mean fluorescence, (n = 20). Oligonucleotides for
construction of GST fusion proteins see Table S2.
doi:10.1371/journal.ppat.1000684.g002
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compared to GE11 cells (Figure 2C). Interestingly, GST-CagY,
but not the other GST fusion proteins, bound more efficiently
when the integrins were activated by Mn2+. The Yersinia invasin
(GST-Inv397) [20], known to specifically bind b1 integrin, showed
a similar behaviour in these binding assays as the GST-Cag
proteins (Figure 2C). To exclude that these GST fusion proteins
would bind unspecifically to the GE11b cells, we also generated
unrelated cag-PAI GST fusion proteins, such as GST-Cagb
(HP0524), GST-CagG (HP0542) and GST-CagZ (HP0526),
which did not show b1 integrin-specific binding to the cells
(Figure S2B). These data confirmed the b1 integrin-specific
binding of CagI from the YTH assay and verified CagI as an
additional cag-T4SS component interacting with b1 integrin.
Unexpectedly, neither a1b1, nor a5b1 integrin beads specifically
pulled down CagL from membrane or soluble fractions of Hp wt
cells using our precipitation conditions (data not shown). We
therefore also generated GST-CagL and GST-CagL-RAD mutant
protein. Although both purified proteins revealed a rather weak
interaction to b1 integrin, the binding was completely independent
from the RGD motif of CagL (Figure S2C).
Taken together, these data verified CagA (the translocated
effector protein), CagY and CagI as direct interaction partners of
different b1 integrin heterodimers. The fact that b1 integrin in
combination with different integrin a chains (a1, a5) precipitated
the Cag proteins confirmed that these proteins bind to the b1
subunit, rather than the a subunit of the heterodimer and strongly
support the YTH results.
Localization of CagY and CagA Along the T4SS Pilus or
Tip
To allow binding of CagA, CagY and CagI to the integrin
receptor, these T4SS components should be accessible at the
surface of the T4SS pilus. CagY is known as an essential
component of the membrane-spanning T4SS complex, but in
addition its surface- or T4SS pilus-association has also been
demonstrated [12,13]. In addition to CagY, we also verified CagA
on the pilus by field emission scanning electron microscopy
(FESEM) (Protocol S1) (Figure S3) [12]. Anti-CagA-coupled gold
particles preferentially labelled the pilus tip, with one or rarely two
gold grains only, but no staining of the pilus base and only rare
background staining of the bacterial or eukaryotic cell surfaces was
visible (Figure S3A-I). To investigate a binding of the cag-T4SS
pilus to b1 Integrin during the infection process, confocal laser
scanning microscopy (CLSM) and life cell imaging were applied.
The gfp-expressing Hp P12 wild type (wt) strain, but not the equally
well binding P12DPAI mutant strain, showed a rapid co-
localization with b1 Integrin upon infection of AGS cells
(Figure 1E). Quantification data revealed that roughly 10% of
Hp P12 wt or P12DcagA, but only 2.5% of P12DPAI bacteria co-
localized with b1 Integrin (Figure 1D). A P12DcagA deletion
mutant still showed co-localization to b1 integrin, which can be
explained by its binding via CagY or CagI.
The RGD Motif in CagL is not Essential for T4SS Function
We wondered why CagL was detected neither in our YTH
screen, nor the pulldown assays. To reassess the described RGD-
dependent interaction of CagL and a5b1 integrin [14], we first
generated a defined cagL deletion mutant in Hp P12. The strain
was genetically complemented in the Hp recA locus by mutated
cagL genes encoding RAD, RGA or DRGD versions of CagL
(Figure 3A). AGS cells infected with the P12DcagL strain failed to
translocate CagA and to induce IL-8, as described earlier [11,14],
but surprisingly all three distinct Hp cagL mutant strains (cagL-
RAD, cagL-RGA and cagLDRGD) behaved identical to the P12 wt
strain concerning CagA translocation, as well as IL-8 induction
(Figure 3B). This clearly indicated that under infection conditions
an RGD-mediated interaction of CagL with a5b1 integrin either is
not existent, or not necessary for CagA translocation, or for IL-8
induction.
Binding of CagA to b1 Integrin with High Affinity
To judge the specificity and the strength of CagA binding to b1
integrin, surface plasmon resonance measurements were per-
formed. The expression of recombinant CagA is problematic
because the protein is rapidly degraded [21,22]. We considered
this property as we purified a stable N-terminal fragment
(100 kDa) of CagA, lacking the C-terminal 33kDa domain [22].
The protein was used for binding studies with purified a5b1
integrin and aVb3 integrin (Clontech) as a negative control. CagA
binds with high affinity to a5b1 integrin (KD= 0.153+/
20.096 nM) (Figure 3C) and with a 2-log higher KD value to
aVb3 integrin (KD= 33.4+/218 nM) (Figure 3D), demonstrating
the avidity and the specificity of CagA for b1 integrin binding.
Thus, the KD value of a5b1 and CagA is approximately
hundredfold lower as compared to the same integrin with its
cognate ligand, fibronectin, which is dependent on an RGD motif
(KD= 15 nM) [23]. This strong and specific binding suggests an
important function for this interaction.
Integrin Clustering is Essential for CagA Translocation,
but not Signalling via the b1 Integrin Cytoplasmic Tail
Specific binding of CagA or CagY to the b1 integrin subunit of
the heterodimer on the host cell surface might stimulate integrin
clustering and internalization. Cholesterol depletion of AGS cells
by methyl-b-cyclodextrin strongly reduced CagA translocation in
a dose and time-dependent manner (Table 1). Calpeptin inhibits
the Ca2+-dependent protease calpain, which is required for the
release of integrins from the cytoskeleton and for clustering in lipid
rafts. Calpeptin treatment completely abrogated CagA transloca-
tion (Figure S4, Table 1) and together with the methyl-b-
cyclodextrin data strongly suggested that the organization of b1
integrins into lipid rafts and integrin clustering is essential for
CagA translocation, as recently confirmed [24].
To clarify whether b1 integrin-mediated signalling might be
necessary for CagA translocation, we used CHO cells stably
transfected with either a full-length human b1A gene, a deletion
comprising the complete cytoplasmic tail (b1TR) or constructs
containing only the transmembrane and the common region of the
b1A tail (b1COM) [25]. Surface expression of b1A integrin was
verified by flow cytometry (data not shown). With exception of the
CHO vector control, all cell lines were competent for CagA
translocation by Hp P217 and with lower efficiency in the P12
strain (Figure 4A). The generally low efficiency of CagA
translocation into b1 reconstituted CHO cells might be due to a
combination of human b1 integrin with the endogenous hamster a
integrin chains. Nevertheless, these data suggest that the
cytoplasmic tail of b1 integrin and therefore outside-in signalling
via the integrin b1 chain is not essential for CagA translocation,
although these data do not exclude that such a signalling occurs
under in vivo conditions.
To further substantiate these findings and to prove whether
CagA translocation via the T4SS may occur independently of b1
integrin signalling, we applied an integrin linked kinase (ILK) gene
knockdown. ILK binds to the b1 integrin cytoplasmic domain,
thereby directly coupling outside-in integrin signalling to a variety
of downstream signal transduction pathways [26]. Production of
the ILK protein was reduced by ,80% at 60h after transfection of
the ILK siRNA (Figure 4B). Interestingly, knockdown of ILK had
b1 Integrin Engagement for CagA Translocation
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no effect on the capacity of CagA translocation by any of the three
Hp strains used (Figure 4B), providing strong evidence that CagA
translocation solely depends on the extracellular part of b1
integrin and its clustering in lipid rafts, but does not necessarily
need the b1 integrin/ILK downstream signalling pathway.
Interference with CagA Translocation
b1 integrin heterodimers binding to ligands, such as fibronectin,
collagen or laminin, involves the a chain and the b chain [27].
Integrin head domains are able to adopt two alternative
conformations, termed open (high affinity) and closed (low
affinity), which are modulated via binding of metal ions, such as
Ca2+ (stabilising closed conformation, deactivating), or Mg2+ or
Mn2+ (stabilising open conformation, activating). [27]. Deactiva-
tion of integrins by treatment with Ca2+ or EDTA did not
interfere, but the intracellular Ca2+-chelator BAPTA significantly
reduced either translocation or tyrosine-phosphorylation of CagA
in AGS cells. In contrast, extracellular activation of integrins
(Mn2+) significantly enhanced CagA translocation and its tyrosine-
phosphorylation (Table 1). Treatment of AGS cells with proteases,
such as trypsin or thrombin, which leads to detachment of the
cells, but not cleavage of integrin heterodimers, resulted in slightly
enhanced, rather than abrogated CagA translocation efficiency
(Table 1). This observation might possibly be explained by an
indirect activation of b1 integrin through Proteinase-Activated
Receptor-2 (PAR-2) [28]. Natural ligands of a5b1 integrin, such as
Figure 3. Construction and functional characterization of Hp P12 strains producing CagL proteins with defined amino acid
exchanges in the RGD motif and CagA binding to b1 integrin. (A) Immunoblot of P12 wt and P12DcagL strains genetically complemented by
a cagL wt or a mutated gene carrying a RAD or a RGA exchange, or an RGD empty site (DRGD). (B) Sandwich ELISA to determine the IL-8 secretion of
AGS cells infected by P12 wt or specific cagL mutant strains. (C) Surface plasmon resonance sensograms of the interaction of immobilized CagA
(stable 100 kDa N-terminal fragment) with integrin a5b1 (left) and aVb3 (right) (0.07–1.12 ng/ml) shown in resonance units (RU). The following
concentrations of integrin were used: magenta, 0.07 ng/ml; green, 0.14 ng/ml; red, 0.28 ng/ml; grey, 0.56 ng/ml; blue, 1.12 ng/ml. (n = 10 individual
measurements and KD calculations).
doi:10.1371/journal.ppat.1000684.g003
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fibronectin, Yersinia enterocolitica invasin [29] or RGD peptides, even
in high quantities, did not alter CagA translocation efficiency
(Table 1).
We next used a set of specific anti-b1 monoclonal antibodies
(mAbs), including stimulatory (N29, 8E3, 12G10, 9EG7, B3B11),
inhibitory (JB1A, AIIB2), and neutral ones (K20, LM534), to
check for interference with the binding of Cag proteins to b1
integrin and thus eventually block CagA translocation (Table 1).
Antibodies targeting different domains of b1 integrin were shown
to bind to AGS cells (Figure 5A,D). These well-defined mAbs
cover essentially all domains and conformations of the b1 integrin
chain (Figure 5A), but with the exception of 9EG7, none of them
was able to interfere with CagA translocation (Figure 5B,C and
Table 1). According to its function, mAb AIIB2 detached AGS
cells from the tissue culture plate. This is due to its interaction with
the ligand binding domain and its b1 integrin deactivation, but
this binding did not block CagA translocation (Figure 5B). Thus,
our data show a novel type of interaction of the cag-T4SS with b1
integrins, which is independent of the integrin a chain and a
typical integrin/ligand interactions, as well as RGD-motifs in any
of the Cag proteins.
Locking Integrin in its High Affinity Conformation Blocks
CagA Translocation
Several studies have indicated that a close apposition of the a and
b subunits in the membrane-proximal region and the so-called bent
structure of the heterodimer are characteristic for the low affinity
state of integrins [30,31]. In contrast, the extended conformation,
characterized by separated legs (comprising the b1 I-EGF1-4/b-tail
and the a chain Calf-1/Calf-2 domains), represents the high affinity
state [15]. Certain allosteric b1 integrin antibodies are able to
modulate integrin activity rather specifically by stabilizing a distinct
affinity state of the integrin [32]. 9EG7 is a b1-specific mAb with a
binding epitope in the I-EGF2-4 region, which is strongly exposed
upon manganese treatment or ligand binding (Figure 5E) [33]. The
mAb 9EG7 stabilizes and probably fixes conformational changes in
the integrin heterodimer, which means that 9EG7 binding of
activated integrin will no longer allow its inactivation/bending.
Table 1. Ligands or inhibitors of integrin signalling and their effect on CagA translocation.
Treatment Concentration Target CagA Translocation Ref
None - - +++ -
Integrin activating and -
inactivation Ions this study
CaCl2 10 mM Extracellular inhibitor of Integrin, binding of fibronectin +++ this study
MnCl2 2 mM Extracellular activator of Integrin, binding of fibronectin ++++ this study
EDTA 0.8–1.2 mM Extracellular divalent cation chelator (Ca2+ & Mg2+) +++ this study
BAPTA 60 mM Intracellular calcium chelator + this study
Proteases, Integrin ligands, antibodies -
8E3 30 mg/ml Stimulatory mab, binds inactive form of the b1 integrin
PSI domain
+++1 [40]
N29 30 mg/ml Stimulatory mab, binds b1 integrin PSI domain +++1 [41]
JB1A 30 mg/ml Inhibitory mab, binds b1 integrin PSI domain +++1 [42]
AIIB2 30 mg/ml Inhibitory mab, inactivates b1 integrin binding to
substrate
+++1 [43]
12G10 30 mg/ml Stimulatory/inhibitory mab, binds to active form of b1 +++1 [44]
K20 30 mg/ml Neutral mab, binds to hybrid/EGF-like region of b1 +++1 [45]
LM534 30 mg/ml Neutral mab, binds to hybrid/EGF-like/b-tail region of b1 +++1 [46]
B3B11 30 mg/ml Stimulatory mab, binds to b-tail region of b1 +++1 [41]
9EG7 30 mg/ml Stimulatory/inhibitory mab, binds EGF-like region of
activated b1
21 [33]
Trypsin 10 mg/ml Digestion of extracellular proteins ++++ this study
Thrombin 4 U/ml Digestion of extracellular proteins ++++ this study
RGD peptide 5–100mg/ml Binding to vWF domain of integrin Competition of
binding to fibronectin
+++1 this study
RAD peptide 5–100mg/ml Peptide control of RGD +++1 this study
Invasin 197 & 397 5 mg/ml Binding to b1 integrin (CD29), induces uptake +++1 this study
Fibronectin 100–10 mg/ml Ligand of a5b1 integrin +++1 this study
Inhibitors membrane signaling & lipid
raft formation
-
Methyl-b-cyclodextrin 0.1 g/ml Cholesterol depletion from membranes. Lipid rafts
disturbance
(+)2 this study
Calpeptin 280 mM Serine/threonine protease inhibitor, inhibits calpain
proteolytic activity
2 this study
1Cells synchronized before treatment.
2Strain-dependent.
doi:10.1371/journal.ppat.1000684.t001
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Interestingly, mAb 9EG7 completely blocked CagA transloca-
tion in AGS cells, whereas Mn2+ alone enhanced, rather than
reduced CagA translocation (Figure 5B). A papain-generated Fab
fragment of mAb 9EG7 binds in a Mn2+-dependent way to the
integrin receptor (Figure 5F), but is unable to block CagA
translocation (Figure 5C). A direct competition for binding of
9EG7 and GST-Cag proteins to the same integrin epitope was
excluded, as measured by FACS analysis (Figure 5G).
The important function of the integrin activation state was
supported by the human cervix cell line HeLa. This cell line
produced normal levels of b1 integrin on the cell surface, as
determined by flow cytometry (data not shown), but was only very
inefficiently, or not at all able to act as host cell for CagA translocation
by certain Hp strains (Figure 6A). An in vitro phosphorylation assay
ruled out a possible defect in CagA tyrosine phosphorylation (data
not shown). The binding capacity of mAb 9EG7 revealed a 20%
difference between non-activated and activated (Mn2+) state of the
cells, whereas for AGS cells the difference was approx. 65%. These
data suggest that, due to an unknown mechanism, HeLa cells
apparently produce constantly activated b1 integrin, which might be
locked in the active state unable to switch back to the closed, inactive
conformation, similar to the situation obtained by 9EG7 binding.
This could explain the limited ability of Hp to translocate CagA.
Discussion
The cag-Type IV Secretion System (cag-T4SS) of Hp constitutes
one of the most important virulence factors of this gastric bacterial
pathogen. The mechanism by which Hp translocates CagA into
host epithelial cells is still not well understood. An important
finding was that the cag-T4SS apparently does not inject its effector
protein CagA randomly into target cells, but uses the a5b1
integrin as a cellular receptor for the pilus-associated adhesin
CagL [14]. CagL is the only cag-PAI encoded protein carrying an
RGD sequence, which is present in certain extracellular matrix
proteins and known as a typical integrin/ligand interaction motif
[34].
In the present study, we describe the mammalian b1 integrin in
different combinations with integrin a chains as a receptor for the
Hp T4SS. Convincing data for a functional role of b1 integrin
were obtained by the promyelocytic HL60 cell line. Non-
differentiated promyelocytic HL60 cells, producing high levels of
b1 integrin on their cell surface, but not differentiated dHL60
cells, with low levels of surface-associated b1, translocated CagA
very efficiently (Figure 1A,C). These data were substantiated by
using integrin-deficient murine fibroblast (GD25) or epithelial
(GE11) cells, which were completely resistant to CagA transloca-
Figure 4. b1 Integrin signalling is dispensable for CagA translocation. (A) CagA translocation assay using Hp strains P12 and P217 and CHO
cells stably expressing either no (CHO K1), the b1A (complete gene), the b1COM (only common region of cytoplasmic tail) or the b1TR (no
cytoplasmic tail) version of the human b1 integrin gene. For a full description of the truncated b1 gene constructs please refer to [25]. Filled
arrowheads depict CagA-P, open arrowheads CagA. ext, integrin external region, TM, transmembrane region. (B) Lysates of AGS epithelial integrin
linked kinase (ILK) knockdown cells (siRNA-ILK) and cells transfected with GC-matched oligonucleotides (siRNA-Control) or lipofectamine-transfection
(Mock-Transfection) were immunoblotted with a-ILK (Sigma) and anti-tubulin antibodies (loading control). The level of ILK knockdown was
determined to be 86% by densitometry. AGS wt, ILK knockdown or control cells were infected with Hp strains, as indicated. Cell lysates were
immunoblotted with a-phospho-tyrosine (PY99) or a-CagA antibodies (AK257). Bands representing CagA-P or CagA are marked by filled arrowheads,
open arrowheads depict tyrosine-phosphorylated host cell proteins.
doi:10.1371/journal.ppat.1000684.g004
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Figure 5. Interference with CagA translocation using b1 integrin-specific monoclonal antibodies. (A) Mapped binding sites of anti-b1
integrin mAbs and their capacity to block CagA translocation are indicated (see also Table 1). (B) Pre-treatment of synchronized AGS epithelial cells by
b1-specific mAbs (30mg, 1h or 3h), or (C) Pre-treatment of synchronized AGS epithelial cells by mAb 9EG7 or its Fab fragments generated by papain
digestion (15mg, 1h or 3h). After Hp infection CagA translocation was determined (CagA-P, tyrosine-phosphorylated CagA, PY99), CagA and b1
Integrin were used as loading controls. (D) Verification of b1 integrin antibody binding to AGS cells, as determined by FACS (MF, mean fluorescence
(a-mouse and a-rat AlexaFluor488). (E) Quantification of 9EG7 binding to AGS cells with or without Mn
2+ treatment by flow cytometry. (F)
Quantification of 9EG7 Fab fragment binding to AGS cells with or without Mn2+ treatment by flow cytometry. (G) Quantification of binding of GST-
CagA, GST-CagYc or GST-CagI to AGS cells treated with Mn2+ or Mn2+ and mAb 9EG7 by FACS analysis, to determine a possible competition in
binding of GST fusion protein and 9EG7. # indicates no significant difference.
doi:10.1371/journal.ppat.1000684.g005
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tion by Hp, but could be functionally restored upon re-expression
of the b1 integrin (GD25b, GE11b) (Figure 1B).
Here, we performed a systematic YTH screen to identify all
proteins of the cag-PAI interacting with the b1 integrin receptor.
We identified the translocated effector protein CagA, the C-
terminal domain of the secretion apparatus component CagY and
CagI as binding partners of the integrin receptor. Biochemical
evidence for a receptor function of a1b1 (a collagen and laminin
receptor) or a5b1 integrin (a fibronectin receptor) was obtained by
(i) pulldown experiments using Hp lysates (Figure 2B), (ii) direct
binding of the corresponding GST-Cag fusion proteins to b1
integrin as determined by FACS analysis (Figure 2C), or (iii) by
surface plasmon resonance measurements (Figure 3C,D). CagA
binds b1 integrin with a significantly lower KD value as a5b1
integrin binds in a RGD dependent way to fibronectin, its natural
ligand. CagA affinity for aVb3 is significantly lower (approx. 100-
fold) as compared to a5b1, demonstrating the high specificity of
CagA for the b1 heterodimer. CagA also binds with significantly
higher affinity as postulated for CagL to a5b1 integrin. CagA
carries a C-terminal translocation signal, but also the N-terminus
is essential [19]. So far, the role of the N-terminal portion of CagA
had remained elusive, but this specific binding to b1 could explain
its important role in the translocation process. The exceptionally
high affinity of CagA for the integrin receptor might compensate
for the relative low abundance of CagA at the tip of the cag-T4SS
pilus and suggests an important function for the surface-associated
CagA. The integrin binding might have a structural role in
triggering integrin rearrangements, whereas only the cytoplasmic
(non-pilus-associated) CagA might act as the translocated effector
molecule when a translocation-competent configuration has been
established (see model Figure 7).
Whereas our data support the essential role of b1 integrin for
the process of CagA translocation, the RGD-dependent binding of
CagL to the integrin receptor could not be verified. Using Hp
extracts, we were able to show here a direct interaction of native
(non-recombinant) CagA or CagY with integrin heterodimers,
however we could not confirm an interaction of native CagL with
the a5b1 integrin. It is possible that in the native pilus-associated
CagL the RGD motif is buried within the protein and not
accessible to interaction. In recombinant overexpression systems,
this motif could be exposed, due to partially incorrect folding. Our
genetic complementation data support this theory. We are able to
successfully rescue CagA translocation with the complementation
of CagL mutants, independently of the RGD status of the protein.
Possible failures in complementation are known for Hp due to
frequent secondary mutations, often in the cag-PAI [35]. In
support of these genetic data we also showed that binding of GST-
CagL protein to b1 integrin is very low, as compared to CagA,
CagI or CagYc. More important, the binding of purified GST-
CagL to b1 integrin was completely independent from its RGD
motif. Thus, we show on the functional as well as on the binding
level that the RGD motif of CagL is not essential for the protein
function.
To further study the type of interaction between the b1 integrin
heterodimer and the Cag proteins, we used typical b1 integrin
ligands, such as RGD peptide, fibronectin or Yersinia invasin
protein, to possibly interfere with CagA translocation (Table 1).
None of these known ligands was able to block CagA
translocation, indicating that the Cag proteins use different sites
on the integrin for interaction. Kwok et al showed that Escherichia
coli strain HB101 that expresses Yersinia invasin inhibited CagA
phosphorylation in AGS cells. It might be possible that E. coli
expressing invasin on the surface could sterically inhibit H. pylori to
bind and translocate CagA, just by blocking the access to the
integrins.
Interaction of integrins with its ligands results in integrin
clustering. Inhibition of integrin clustering into lipid rafts using
methyl-b-cyclodextrin or calpeptin strongly reduced CagA trans-
location, indicating that Hp-mediated clustering of b1 integrin
heterodimers on the cell surface might be essential for this process.
To determine whether integrin signalling might play a role for
CagA translocation, signalling-deficient, truncated versions of b1
integrin receptor were used. Unexpectedly, neither the b1 integrin
cytoplasmic tail, nor signalling via the integrin linked kinase was
necessary for CagA translocation, indicating that only the
extracellular domains of the b1 integrin is important. CHO cells
derived from hamster generally showed a lower CagA transloca-
tion efficiency as compared to human AGS cells (Figure 4A). We
assume that human/hamster integrin heterodimers, generated
upon transfection are the reason, an effect also seen for murine
GE11 cells (human/mouse integrin heterodimers) (Figure 1B). H.
pylori P217 shows a very strong CagA phosphorylation in AGS
cells due to its high number of EPIYA motifs (8 motifs as
Figure 6. HeLa cells are inefficient for CagA translocation and
produce constitutively active b1 integrin. (A) Human gastric AGS
and HeLa cells were infected with Hp strains P12 P217 and P145 and
CagA translocation was determined by immunoblotting with antibody
PY99 (CagA-P). Equal loading of bacteria and cells was determined by
CagA (AK257) and b1 integrin detection (LM534). (B) Quantification of
binding of mAb 9EG7 to AGS or HeLa cells with or without Mn2+
treatment by flow cytometry.
doi:10.1371/journal.ppat.1000684.g006
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compared to 4 in P12), resulting in more efficient tyrosine
phosphorylation as P12 in CHO cells.
To obtain insight which domains of the extracellular part of the
integrin receptor are important, a set of defined monoclonal
antibodies against various b1 integrin domains were applied
(Figure 5A, Table 1). None of these antibodies, even those blocking
the integrin ligand interaction (AIIB2, 12G10), were able to block
CagA translocation, except mAb 9EG7. This is in contrast to many
viruses, which use integrins as receptors or co-receptors for entry
into different host cells [36–38]. Most viruses known to use integrins
as entry receptors have been shown to do so by extracellular matrix
(ECM) protein mimicry, which means that viral proteins contain an
RGD or any other conserved integrin recognition motif. Thus,
specific antibodies, which block integrin ligand interaction, usually
abrogate virus infection in vitro [36–38]. Taken together our data
suggest that the cag-T4SS uses the extracellular portion of integrin to
mediate entry of the effector protein into the cell by a different
mechanism, probably independent from ECM protein mimicry and
the usual integrin ligand interaction.
What is the difference in the effect of mAb 9EG7 in comparison to
all the other b1 specific mAbs used in this study? 9EG7 binds an
epitope in the b1 integrin which is close to the fulcrum at the genu
and is buried in the inactive (bent) state of the integrin receptor. Mn2+
treatment or ligand binding opens the integrin into the extended
conformation and the epitope is free for antibody binding. When
9EG7 is bound, the integrin cannot move back into the bent
conformation, probably due to sterical problems with the bulky Fc
part of the antibody or its ability to crosslink integrin chains. In
addition, we cannot exclude the possibility that 9EG7 might prevent
the interaction of the b1 integrin subunit with a co-receptor necessary
for the translocation process, although there is no evidence for a co-
receptor being involved. The 9EG7 Fab fragment still needs
activation of the integrin for binding (Figure 5E,F). This indicates
that its binding is unchanged, but the lack of the Fc chain will not
cause the effects presumed for the complete mAb, due to the smaller
size of the Fab fragment and its inability to crosslink. Our data lead us
to propose a model whereby the rearrangement of the integrin from
the extended, open conformation, binding the T4SS components, to
a bent conformation (bent closed) is an essential step in the process of
CagA translocation (see Figure 7 for a model). We propose that this
mechanics of the integrin, which is associated with a closer
approximation of the integrin head to the cellular membrane [27],
brings the pilus closer to the cellular membrane. When this
conformational change is inhibited, CagA translocation cannot occur.
Materials and Methods
Bacterial strains, cell lines and culture conditions
Hp Strains. Hp strains P12, P145 and P217 and the isogenic
knockout mutants P12DcagA, P12DcagE, P12DcagY as well as
P12DPAI and P217DPAI, lacking the entire cag pathogenicity
island, have been constructed as previously described for the
corresponding mutant strains in Hp 26695 [11]. Hp strains were
grown on GC agar plates (Difco) as described previously [11].
Eukaryotic cell lines. Eleven different eukaryotic cell lines
were analyzed for their capacity to tyrosine-phosphorylate Hp
translocated CagA and IL-8 induction (Table S1). Cells were
grown in media as indicated and subcultured every 2 to 3 days.
Figure 7. Proposed working model for b1 integrin acting as a receptor of the cag-T4SS pilus for translocation of CagA protein. Hp
T4SS pili (consisting of the pilus subunit CagC) are decorated by proteins CagA, CagY, CagL and probably CagI. The pilus associated proteins contact
b1 integrin in the open extended conformation of the head, leading to the clustering of the integrin heterodimers. These binding events may induce
a change at the legs of the integrin a/b chains, moving both legs together, which results in a closing and downward movement of the integrin head
domains (bent, closed conformation) [39], which seems to be essential for CagA delivery. The mAb 9EG7 binds to the EGF-like domains of the b1 legs
and stabilizes the open conformation by preventing a close interaction between the a and b integrin legs (disulfide bridges, indicated by red bars),
which is suggested to prevent the downward movement and therefore a possible membrane insertion of the T4SS pilus and thus CagA delivery. a,
alpha integrin subunit; b, beta integrin subunit; ILK, integrin-linked kinase; A, CagA; Y, CagY; L, CagL protein; E, EGF-like1-4; b, b-tail domain; H, Hybrid;
I, I-like; P, PSI domain, 9EG7, mAb 9EG7.
doi:10.1371/journal.ppat.1000684.g007
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Antibodies and reagents
Antibodies against phosphotyrosine were obtained from Santa
Cruz (PY99) or Upstate (4G10), polyclonal horseradish peroxidase
(HRP) and alkaline phosphatase-conjugated anti-mouse IgG, anti-
rat IgG and anti-rabbit IgG antisera, HRP-conjugated streptavi-
din, Heptakis(2,6-di-O-methyl)-b-cyclodextrin (Heptakis), fibro-
nectin from human plasma, RGD (Gly-Arg-Gly-Asp-Ser-Pro-Lys)
and RAD (Gly-Arg-Ala-Asp-Ser-Pro-Lys) peptides, protease
inhibitors PMSF, Leupeptin and Pepstatin were obtained from
Sigma. Purified human a1b1 (from smooth muscle), a5b1 (from
placenta) and aVb3 (from placenta) were purchased from
Clontech (Millipore). Integrin a5b1 and monoclonal anti-b1
integrin Clone LM534 were purchased from Chemicon Interna-
tional. CD29 FITC and CD18 PE were purchased from BD
Biosciences, and anti-b1 integrin antibody (Clone 4B7) was from
Calbiochem. Rat anti-human b1 integrin inactivating antibody
AIIB2 was extracted from hybridoma cells supernatant. For
antibodies and their sources see Table 1. To detect CagL, a rabbit
antibody against a purified CagL fusion protein was used [18].
Yeast two hybrid assay
The Invitrogen system consisting of the entry vector
pDONR207 and the destination vectors pDEST-GADT7 (prey
vector) and pDEST-GBKT7 (bait vector) were used. Yeast two-
hybrid bait and prey libraries were generated comprising the
external b1 integrin gene sequence and the cag-PAI genes. For the
cag-PAI genes, 22 full-length open reading frames (excluding N-
terminal signal sequences), and 10 partial open reading frames
were amplified from chromosomal DNA of strain 26695 by nested
PCR, and cloned in the bait and prey vectors exactly as described
[18]. Bait and prey plasmids were transformed into the haploid
Saccharomyces cerevisiae strains Y187 and AH109. Diploid yeast cells
were selected after mating and selection on SD medium lacking
tryptophan (Trp2) and leucine (Leu2), thus generating all possible
combinations of bait and prey plasmids. After growth on SD-
Trp2Leu2 medium, yeast colonies were transferred to SD-
Trp2Leu2His2 medium in order to select for interactions.
Growth after 3 to 6 days indicated bait-prey interactions.
Additionally, the stringency of this screen was enhanced by
selection on SD-Trp2Leu2His2 medium containing the compet-
itive inhibitor 3-aminotriazole (5 mM).
Phosphorylation assays
Cells were infected with Hp at 70–90% confluency with a
multiplicity of infection (MOI) of 60. For synchronization
experiments, cells were detached with PBS/2 mM EDTA, seeded
and after 24 hours synchronized overnight in serum free media.
Before infection, RPMI (GIBCO) complete media (CM) containing
10% Fetal Calf Serum (GIBCO) was added to cells, counting this
point as time 0. To test different inhibitors, 1, 2 and 4h infections
were performed after 60 min from addition of CM. After infection,
supernatants from 2 & 4h experiments were collected, cells were
harvested in PBS with protease inhibitors (pepstatin 1mM, leupeptin
1mM, PMSF 1mM) and phosphatase inhibitor sodium vanadate
(1mM). Harvested cells were centrifuged at 5006g for 10 min at
4uC and pellets lysed in RIPA buffer with protease and phosphatase
inhibitors and DNase I for later SDS-PAGE and immunoblot
analysis under non-reducing conditions.
Pull-down assays and immunoblotting
SiMAG magnetic beads (Chemicell) were coated with 50 mg
a5b1 integrin/10 mg beads following the manufacturer’s instruc-
tions. Beads were saturated with 1 M Tris-HCl (pH 7.5). 1 ml Hp
(OD550 of 2) in PBS with protease inhibitors was treated with
lysozyme (10 mg/ml, 4 mM EDTA) for 30 min at RT, DNase I
was added (1 mg/ml) and bacteria were lysed by ultrasonication on
ice. Soluble proteins (Soluble I) and membranes were separated by
ultracentrifugation. Membranes were resuspended in 1 ml HSL
(High Salt Lysis, 25mM Tris-HCl, pH 7.4, 0.05% Triton-X100,
4 mM MgCl2, 3 mM MnCl2, 150 mM NaCl) buffer with protease
inhibitors, sonicated and centrifuged at 4uC, 13.000 rpm for 1min
to collect the soluble fraction (Soluble II). Soluble II was used for
protein pulldown. After pulldown, 3ml beads were incubated at
4uC for 1 h, washed 3 times with HSL 400 (HSL with 400 mM
NaCl) buffer, boiled and used for SDS-PAGE (non-reducing
conditions). Proteins were transferred to PVDF membranes, and
blotted with the antisera indicated. Blots were routinely stripped
and reprobed with the indicated antisera (a-actin or a-b1 integrin
antibodies) as loading controls. Blots shown are representative of
three independent experiments.
Live cell imaging
For co-localization experiments the integrin b1-specific mono-
clonal antibody 4B7 was labelled with AlexaFluor568 according to
the manufacturer’s instructions (10 mol Alexa Fluor568/mol
antibody). AGS cells were grown in 35 mm glass bottom dishes
(MatTek) to 60–70% confluency. Cells were washed once with
PBS (without Ca2+ and Mg2+) and infected with GFP-expressing
P12 wt or P12DPAI grown on serum-free media at an MOI of 60.
2 mg/ml Alexa Fluor 568-labelled antibody against b1 integrin was
added. Infection was performed for 7 min. at 37uC and PBS was
exchanged before microscopy studies. For quantification of co-
localization, assays were recorded over a time range of 50s and
picture sequences were analyzed for co-localization events of single
bacteria and integrin b1 clusters. Percent co-localization was
calculated from ratio of bacteria co-localizing with integrin to total
adherent bacteria.
Imaging was done using an UltraView LCI spinning disc
confocal system (PerkinElmer) fitted on a Nikon Eclipse TE300
microscope equipped with a temperature- and CO2-controllable
environment chamber. Images were taken with the black/white
ORCA ER Camera (Hamamatsu). Pictures were taken and edited
using LCI UltraView software. For immunofluorescence assays, an
Olympus BX 64 microscope and Cell ‘P software were used.
Purification of CagA 100 kDa fragment
CagA gene was cloned into a vector expressing an TEV
cleavable His-tag fusion CagA (pHAR3011–CagA) as described in
[22]. Briefly, the protein was expressed in BL21 cells induced o/n
at 20uC with 1mM isopropyl-b-D-galactopyranoside (IPTG).
Harvested cells were lysed by sonication in buffer A (10 mM Na
Phosphate pH7.5, 5mM immidazole, 500 mM NaCl, 10%
glycerol) containing DNaseI, lysozyme, one mini complete
EDTA-free protease inhibitor cocktail tablet (Roche). After
centrifugation, the supernatant was loaded onto a His-trap column
(GE Healthcare) and eluted with a linear gradient of immidazole
(5 to 500 mM) in buffer A. Two major N-terminal fragments
(29 kDa and 100kDa, assessed by the His-tag presence) were
eluted together with minor degradation products. Fractions were
concentrated and the buffer was exchanged to 10mM Tris pH 7.5,
150mM NaCl. The two fragments were separated by gel filtration
using Superdex S75 10/300 GL column (GE Healthcare).
Fractions containing ,95% pure 100 kDa fragment (residue 1
to approximately 885) were pooled, concentrated and reloaded on
the same column to ascertain stability. The protein was finally
concentrated to 1.8 mg/ml.
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Surface plasmon resonance
Using a BiacoreX unit, the purified 100 kDa N-terminal
fragment of CagA was attached to a CM5 chip (BiaCore) using
the standard amine coupling procedure. The flow-cell 1 was
treated similarly without coupling of a protein and was used as a
reference. Integrin binding to the reference was negligible. For the
evaluation of the interaction of proteins, a Tris buffer was used
containing 24 mM Tris-HCl pH 7.5, 137 mM NaCl and 2.4 mM
KCl. Injection of the integrin proteins was for 1 min using a flow
of 60 ml/min. Subsequently, dissociation was evaluated for
200 sec. Regeneration of the chip took place between each
measurement using a solution of Tris 20 mM pH 7.4, 150 mM
NaCl, 1 mM MgCl2, 1 mM CaCl2 and 0.0125% Triton, resulting
in a stable baseline and retaining activity. BiaEvaluation software
(version 4.1) was used for the evaluation of the dissociation
constant using a 1:1 langmuir model of binding.
Generation of 9EG7 Fab fragments
1 mg of 9EG7 mAb (rat) (BD Biosciences) was digested using
beads coupled to Papain (Pierce) following the manufacturers’
instructions. Fab fragments were detected by western blotting
using a rabbit anti rat Fab (Rockland Immunochemicals). Binding
capacity of the Fab fragments to AGS cells was evaluated by flow
cytometry. Secondary antibodies anti-rat Alexa488 and anti-rabbit
Alexa488 were from Molecular Probes.
Statistical analysis
Data are presented as mean+/2SEM. Differences between
groups were assessed by the paired, two-tailed Student’s t-test, or
by the Mann-Whitney U test for unpaired groups depending on
the data set of concern (see figure legends).
Supporting Information
Protocol S1 Supporting methods file
Found at: doi:10.1371/journal.ppat.1000684.s001 (0.04 MB
DOC)
Table S1 Cell lines used in this study and their growth
conditions
Found at: doi:10.1371/journal.ppat.1000684.s002 (0.04 MB
DOC)
Table S2 Oligonucleotides used for the generation of GST
fusion proteins
Found at: doi:10.1371/journal.ppat.1000684.s003 (0.05 MB
DOC)
Figure S1 Protein-protein interactions among H. pylori cag-PAI
proteins and b1 integrin. Yeast cells co-transformed with plasmids
expressing b1 integrin and either HP0527a (CagYa), HP0527b
(CagYb), HP0527c (CagYc), HP0540 (CagI), HP0547a (CagAa) or
HP0547b (CagAb), growing on minimal SD medium lacking
tryptophan and leucine (SD-Trp-Leu) or on selective minimal SD
medium lacking tryptophan, leucine, and histidine (SD-Trp-Leu-
His). Negative and positive controls were used as described.
Found at: doi:10.1371/journal.ppat.1000684.s004 (0.77 MB TIF)
Figure S2 Integrin binding assays. (A) General procedure to
generate Hp extract for pulldown assay with b1 integrin beads.
Total lysate depicts the presence of CagA and CagY in P12 wt
strain. (B) Quantification of binding of purified GST-Cagb, GST-
CagG, GST-CagZ (negative controls for integrin binding) or
GST-Inv397 (positive control) (30mg/16106 cells) to integrin-
deficient GE11 versus integrin-proficient GE11b cells by flow
cytometry (n = 4). (C) Quantification of binding of purified GST-
CagL or GST-CagL(RAD) (30mg/16106 cells) to integrin-
deficient GE11 versus integrin-proficient GE11b cells by flow
cytometry (n = 6). Binding was analysed by anti-GST antibody
(fold increase in binding versus GST, the values for binding of
GST alone has been set to 1). (*, p,0.05; **, p,0.01; ***,
p,0.001; students T-test). MF, mean fluorescence.
Found at: doi:10.1371/journal.ppat.1000684.s005 (0.63 MB TIF)
Figure S3 High resolution FESEM micro-graphs of AGS cells
infected with H. pylori. (A–F) CagA labelling is repeatedly found on
the tip region of the secretion pilus using immunogold labelled
antibody AK273 (arrows) (G–I) P12DPAI strain showing only few
gold-particles on the AGS cell surface (arrows in G and H); in
control experiments with H. pylori-infected AGS cells incubated
with the gold marker alone no labelling in the tip region of the
secretion apparatus is detectable. The background labelling was
comparable to the DPAI strain (arrows in I). (K–L) Localization of
CagY protein on the OM and the cag-T4SS pilus of Hp 26695 wt,
but not 26695DPAI using immunogold-labelled antiserum AK273
by FESEM. Bars represent 200 nm (A–F,K), 1 mm (G), 500 nm
(H,I,L).
Found at: doi:10.1371/journal.ppat.1000684.s006 (6.78 MB TIF)
Figure S4 Pharmacological Iinhibitors interfering with CagA
translocation in AGS epithelial cells. CagA translocation into AGS
cells is inhibited by calpeptin (CP), an inhibitor of the Ca2+-
dependent protease calpain. CP, calpain. Filled arrowheads mark
CagAP-tyr, open arrowheads mark CagA bands.
Found at: doi:10.1371/journal.ppat.1000684.s007 (0.79 MB TIF)
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